Abstract
The medicinal chemistry and biomedical applications of gold complexes have been intensively studied over the last decades. Some complexes have been used for the treatment of rheumatoid arthritis, and a considerable number of new metallodrug candidates have been developed as new anticancer drugs and anti-infectives. However, the therapeutic use of gold and its complexes goes back to ancient times and was also of great importance for alchemists until the modern age. In this report, we give an overview of the alchemic medicine between the sixteenth and the early eighteenth century and describe the cytotoxicity and thioredoxin reductase (TrxR) inhibition of a typical “aurum vitae” medicine, which was prepared according to a recipe by Bartholomäus Kretschmar from the seventeenth century. “Aurum vitae” consists of a mixture of gold, mercury and antimony complexes and shows the expected cytotoxic and TrxR inhibitory properties providing some rationale for therapeutic effects of this kind of historical medicinal preparation.
Similar content being viewed by others
References
Shaw CFS (1999) Gold-based therapeutic agents. Chem Rev 99:2589–2600
Eisler R (2003) Chrysotherapy in the treatment of rheumatoid arthritis. Inflamm Res 52:487–501
Ott I (2009) On the medicinal chemistry of gold complexes as anticancer drugs. Coord Chem Rev 253:1670–1681
Nobili S, Mini E, Landini I, Gabbiani C, Casini A, Messori L (2009) Gold compounds as anticancer agents: chemistry, cellular pharmacology and preclinical studies. Med Res Rev 30:550–580
Berners-Price S-J, Filipovska A (2011) Gold compounds as therapeutic agents for human diseases. Metallomics 9:863–873
Navarro M (2009) Gold complexes as potential anti-parasitic agents. Coord Chem Rev 253:1619–1626
Sun RW-Y, Yu W-Y, Sun H, Che C-M (2004) In vitro inhibition of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase by gold(III) porphyrins. ChemBioChem 5:1293–1298
Simon TM, Kunishima DH, Vibert GJ, Lorber A (1981) Screening trial with the coordinated gold compound auranofin using mouse lymphocyte leukemia P388. Cancer Res. 41:94–97
Berners-Price SJ, Sadler PJ (1986) Gold(I) complexes with bidentate tertiary phosphine ligands: formation of annular vs. tetrahedral chelated complexes. Inorg Chem 25:3822–3827
Hunt LB (1976) The true story of purple of Cassius. Gold Bull 9:134–139
Schneider W (1972) Geschichte der pharmazeutischen Chemie. Verlag Chemie, Weinheim, pp 105–106. ISBN: 9783527252640
Stillman JM (2003) The story of alchemy and early chemistry. Dover, New York
Riecke VA (1840) Die neuern Arzneimittel, 2nd edn. Hoffmann, Stuttgart, pp 79–107
Niel JBB (1823) Recherches et observations sur les effets des preparations d’or du Dr. Chrestien dans le tratement de plusieurs maladies, Magazin für Industrie und Literatur, ed. by André-Jean Chrestien, transl. L. Cerutti, Leipzig
Tappeiner H (1919) Lehrbuch der Arzneimittellehre und Arzneiverordnungslehre, 13th edn. Vogel, Leipzig, pp 106–107
Wever E (1922) Krysolgan bei Kehlkopftuberkulose. Beiträge zur Klinik der Tuberkulose und spezifischen Tuberkulose-Forschung 53:52–56
Heisermann KF (1926) Ueber den Lupus erythematodes und seine Behandlung mit Gold. Diss, Marburg
Dohme ARL (1921) J Am Pharm Ass 40:191–196
Solis-Cohen S, Githen Stotesbury T (1928) Pharmacotherapeutics, materia medica and drug action. Appleton, New York/London, pp 653–656
Rubbiani R, Can S, Kitanovic I, Alborzinia H, Stefanopoulou M, Kokoschka M, Mönchensang S, Sheldrick WS, Wölfl S, Ott I (2011) Comparative in vitro evaluation of N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type. J Med Chem 54:8646–8657
Principe LM (1998) In: Claus P, Karin F (eds) Gold, Alchemie. Lexikon einer hermetischen Wissenschaft, pp 157–160
Pagel W (1982) Paracelsus, an introduction to philosophical medicine in the era of renaissance, 2nd edn. Karger, Basel/New York, pp 101–102, 323
Klein U (2005) Technoscience avant la letter. Perspect Sci 13:227–266
Nowotny O (2004) Die Geschichte der Goldmedizin von der Antike über die Zeit der Alchemie bis zur Gegenwart. In: Meyer K (ed) Die Schelenz-Stiftung IV 1989–2003. Wiss. Verl.-Ges., Stuttgart, pp 99–112
Figala K (1998) Quintessenz, Alchemie. In: Claus P, Karin F (eds) Lexikon einer hermetischen Wissenschaft, pp 300–302
Paracelus T (1977) De morbis amentium, Bücher und Schriften, ed. J. Huser, vol II, Hildesheim: Olms (reprint of the edition Basilea 1589)
Keil CH (1748) Compendiöses doch vollkommenes medicinisch-chymisches Handbüchlein, 6th edn. Martini, Leipzig
Paracelsus T (1971) De viribus membrorum interiorum. In: Huser J (ed) Bücher und Schriften Edition, vol I. Olms, Hildesheim (reprint of the edition Basilea 1589), part 2: 5–6
Stahl GE (1728) Materia Medica. Zimmermann und Gerlach, Dresden
Kunckel J (1716) Collegium physico-chymicum experimentale, oder Laboratorium chymicum, Heyl, Hamburg, Leipzig
Kretschmar B (1977) Vier chymische Tractätlein, VD17 39:139490P; Ferguson, Bibliotheca Chemica, vol 2, S. 509, pp 64–66. doi:10.3931/e-rara-5296
Bindoli A, Rigobello MP, Scutari G, Gabbiani C, Casini A, Messori L (2009) Thioredoxin reductase: a target for gold compounds acting as potential anticancer drugs. Coord Chem Rev 253:1692–1707
Gromer S, Arscott LD, Williams CH, Schirmer RH, Becker K (1998) Human placenta thioredoxin reductase, isolation of the selenoenzyme, steady state kinetics and inhibition by therapeutic gold compounds. J Biol Chem 273:20096–20101
Holmgren A, Lu J (2010) Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem Biophys Res Commun 396:120–124
Citta A, Schuh E, Mohr F, Folda A, Massimino ML, Bindoli A, Casini A, Rigobello MP (2013) Fluorescent silver(I) and gold(I)-N-heterocyclic carbene complexes with cytotoxic properties: mechanistic insights. Metallomics 5:1006–1015
Sun RWY, Fong TTH, Li CKL, Yang ZF, Zou T, Siu AFM, Che CM (2013) A dinuclear cyclometalated gold(III)-phosphine complex targeting thioredoxin reductase inhibits hepatocellular carcinoma in vivo. Chem Sci 4:1979–1988
Arner ESJ, Holmgren A (2006) The thioredoxin system in cancer. Semin Cancer Biol 16:420–426
Gandin V, Fernandes AP, Rigobello MP, Dani B, Sorrentino F, Tisato F, Björnstedt M, Bindoli A, Sturaro A, Rella R, Marzano C (2010) Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase. Biochem Pharmacol 79:91–101
Hickey JL, Ruhayel RA, Barnard PJ, Baker MV, Berners-Price SJ, Filipovska A (2008) Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols. J Am Chem Soc 130:12570–12571
Rubbiani R, Schuh E, Meyer A, Lemke J, Wimberg J, Metzler-Nolte N, Meyer F, Mohr F, Ott I (2013) TrxR inhibition and antiproliferative activities of structurally diverse gold N-heterocyclic carbene complexes. Med Chem Commun 4:942–948
Haldar AK, Sen P, Roy S (2012) Use of antimony in the treatment of leishmaniasis: current status and future directions. Mol Biol Int. doi:10.4061/2011/571242
Baiocco P, Colotti G, Franceschini S, Ilari A (2009) Molecular basis of antimony treatment in leishmaniasis. J Med Chem 52:2603–2612
Acknowledgments
The literature research in history of pharmacy and the experimental contributions of Nuray Ates, André Morawetz, Canan Özen and Jan Carlos Quistorf are gratefully appreciated.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Rubbiani, R., Wahrig, B. & Ott, I. Historical and biochemical aspects of a seventeenth century gold-based aurum vitae recipe. J Biol Inorg Chem 19, 961–965 (2014). https://doi.org/10.1007/s00775-014-1135-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-014-1135-4